ToolGen Initiates UK Patent Lawsuit Against Vertex Over Groundbreaking Gene Therapy CASGEVY
ToolGen, Inc. (KOSDAQ: 199800), a biotechnology firm at the forefront of genome editing innovations, has filed a patent infringement lawsuit in the United Kingdom against Vertex Pharmaceuticals and its key manufacturing partners, Lonza and RoslinCT. The legal action centers on Vertex’s approved CRISPR-based gene therapy, CASGEVY, which ToolGen alleges utilizes its proprietary technology without proper […]